Document is current
Any future updates will be listed below
-
Authors
Geethadevi, Anjali https://orcid.org/0000-0001-5486-7919
Ku, Zhiqiang
Tsaih, Shirng-Wern https://orcid.org/0000-0002-9836-4659
Parashar, Deepak https://orcid.org/0000-0002-5062-8950
Kadamberi, Ishaque P.
Xiong, Wei
Deng, Hui
George, Jasmine https://orcid.org/0000-0001-9674-0027
Kumar, Sudhir
Mittal, Sonam https://orcid.org/0000-0002-2268-2319
Zhang, Ningyan
Pradeep, Sunila
An, Zhiqiang https://orcid.org/0000-0001-9309-2335
Chaluvally-Raghavan, Pradeep https://orcid.org/0000-0002-8268-3460
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI R01CA229907)
- License Information
-
More Information
Article History
Received: 7 January 2024
Accepted: 30 April 2024
First Online: 5 June 2024
Competing interests
: P.C.-R, S.P., A.G., Z.K., N.Z., and Z.A. are inventors of a patent PCT/US2022/074276 on OSMR antibody discovery and therapeutic uses. The other authors have no competing interests to declare.
